Clinical Course and Pharmacokinetics Following a Massive Overdose of Amphotericin B in a Neonate
Authors:
- Alan LauALAlan Lau
- Cynthia F. KenyonCKCynthia F. Kenyon
- David KroppertDKDavid Kroppert
- Julia KleinJKJulia Klein
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 28 (3) , 371-378
Abstract
Amphotericin is the drug of choice for the treatment of fungal infections in infants and children. When used in the recommended doses, amphotericin therapy is associated with high rates of adverse effects, including nephrotoxicity, hepatotoxicity, decrease in white blood cells, platelets and hemoglobin, chills, fever and even death (1). We report a case involving a neonate who was exposed to a 50 fold overdose of Amphotericin over a three day period.Keywords
This publication has 6 references indexed in Scilit:
- Pharmacokinetics and adverse effects of amphotericin B in infants and childrenThe Journal of Pediatrics, 1988
- Comparison of the Digitalis Receptor in Erythrocytes from Preterm Infants and AdultsPediatric Research, 1988
- The dissociation between aminoglycoside serum concentrations and nephrotoxicityLife Sciences, 1988
- Tenfold Errors in Administration of Drug Doses: A Neglected latrogenic Disease in PediatricsPediatrics, 1986
- Measurement of amphotericin b in serum or plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Amphotericin B Pharmacokinetics in HumansAntimicrobial Agents and Chemotherapy, 1978